| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |